This piece explains the role of lipoprotein(a) cholesterol as a genetic risk factor for heart disease, highlights its exclusion from routine tests, and discusses emerging gene-targeting drugs that could significantly reduce Lp(a) levels and transform cardiovascular risk treatment
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
hereditary factors influencing cholesterol levels
Five things a heart disease expert says people still get wrong about cholesterolSpotted something wrong on this page? Report a correction.